These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 29624900

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. High-resolution CT features: prognostic significance in peripheral lung adenocarcinoma with bronchioloalveolar carcinoma components.
    Takashima S, Maruyama Y, Hasegawa M, Saito A, Haniuda M, Kadoya M.
    Respiration; 2003; 70(1):36-42. PubMed ID: 12584389
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pathological features and prognostic implications of ground-glass opacity components on computed tomography for clinical stage I lung adenocarcinoma.
    Katsumata S, Aokage K, Ishii G, Hoshino H, Suzuki J, Miyoshi T, Tane K, Samejima J, Tsuboi M.
    Surg Today; 2021 Jul; 51(7):1188-1202. PubMed ID: 33745094
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Solid component ratio influences prognosis of GGO-featured IA stage invasive lung adenocarcinoma.
    Sun F, Huang Y, Yang X, Zhan C, Xi J, Lin Z, Shi Y, Jiang W, Wang Q.
    Cancer Imaging; 2020 Dec 12; 20(1):87. PubMed ID: 33308323
    [Abstract] [Full Text] [Related]

  • 11. Management of Ground-Glass Opacities in the Lung Cancer Spectrum.
    Zhang Y, Fu F, Chen H.
    Ann Thorac Surg; 2020 Dec 12; 110(6):1796-1804. PubMed ID: 32525031
    [Abstract] [Full Text] [Related]

  • 12. Semiquantitative Computed Tomography Characteristics for Lung Adenocarcinoma and Their Association With Lung Cancer Survival.
    Wang H, Schabath MB, Liu Y, Berglund AE, Bloom GC, Kim J, Stringfield O, Eikman EA, Klippenstein DL, Heine JJ, Eschrich SA, Ye Z, Gillies RJ.
    Clin Lung Cancer; 2015 Nov 12; 16(6):e141-63. PubMed ID: 26077095
    [Abstract] [Full Text] [Related]

  • 13. Bronchioloalveolar carcinoma and adenocarcinoma with bronchioloalveolar features presenting as ground-glass opacities on CT.
    Mirtcheva RM, Vazquez M, Yankelevitz DF, Henschke CI.
    Clin Imaging; 2002 Nov 12; 26(2):95-100. PubMed ID: 11852215
    [Abstract] [Full Text] [Related]

  • 14. Discrimination of subtypes of small adenocarcinoma in the lung with thin-section CT.
    Takashima S, Li F, Maruyama Y, Hasegawa M, Takayama F, Kadoya M, Honda T, Sone S.
    Lung Cancer; 2002 May 12; 36(2):175-82. PubMed ID: 11955652
    [Abstract] [Full Text] [Related]

  • 15. Presence of Even a Small Ground-Glass Component in Lung Adenocarcinoma Predicts Better Survival.
    Berry MF, Gao R, Kunder CA, Backhus L, Khuong A, Kadoch M, Leung A, Shrager J.
    Clin Lung Cancer; 2018 Jan 12; 19(1):e47-e51. PubMed ID: 28743420
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical, pathological and thin-section CT features of persistent multiple ground-glass opacity nodules: comparison with solitary ground-glass opacity nodule.
    Kim TJ, Goo JM, Lee KW, Park CM, Lee HJ.
    Lung Cancer; 2009 May 12; 64(2):171-8. PubMed ID: 18799230
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Survival and risk factors for progression after resection of the dominant tumor in multifocal, lepidic-type pulmonary adenocarcinoma.
    Gao RW, Berry MF, Kunder CA, Khuong AA, Wakelee H, Neal JW, Backhus LM, Shrager JB.
    J Thorac Cardiovasc Surg; 2017 Dec 12; 154(6):2092-2099.e2. PubMed ID: 28863952
    [Abstract] [Full Text] [Related]

  • 20. Toward improving prognosis prediction in patients undergoing small lung adenocarcinoma resection: Radiological and pathological assessment of diversity and intratumor heterogeneity.
    Koezuka S, Mikami T, Tochigi N, Sano A, Azuma Y, Makino T, Otsuka H, Matsumoto K, Shiraga N, Iyoda A.
    Lung Cancer; 2019 Sep 12; 135():40-46. PubMed ID: 31447001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.